Company news
Atea Pharmaceuticals, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Atea Pharmaceuticals Announces First Patient Dosed in Phase 2 Virology Trial of AT-527 in Outpatient Setting
February 3, 2021
Atea Pharmaceuticals Expands Senior Management Team with Key Additions in Regulatory Affairs and Investor Relations and Corporate Communications
January 18, 2021
Atea Pharmaceuticals Expands Board of Directors with Appointment of Barbara Duncan
November 5, 2020
Atea Pharmaceuticals Announces Closing of Initial Public Offering
November 2, 2020
Atea Pharmaceuticals Announces Pricing of Initial Public Offering
October 28, 2020
Calls
The 5 newest of 19 calls. Every call is listed under its year.
- Atea Pharmaceuticals (NASDAQ:AVIR) Q2 2026 Earnings Call
Aug 12, 2026
Transcript - Atea Pharmaceuticals (NASDAQ:AVIR) Q1 2026 Earnings Call
May 12, 2026
Transcript - Atea Pharmaceuticals (NASDAQ:AVIR) Q4 2025 Earnings Call
Mar 5, 2026
Transcript - Atea Pharmaceuticals (NASDAQ:AVIR) Q3 2025 Earnings Call
Nov 12, 2025
Transcript - Atea Pharmaceuticals (NASDAQ:AVIR) Q2 2025 Earnings Call
Aug 7, 2025
Transcript
Decks
The 5 newest of 12 decks. Every deck is listed under its year.
- Q2 2026 Earnings Presentation
Earnings · 31 slides · Aug 12, 2026
- Q1 2026 Earnings Presentation
Earnings · 29 slides · May 12, 2026
- Q4 2025 Earnings Presentation
Earnings · 28 slides · Mar 5, 2026
- 44th Annual J.P. Morgan Healthcare Conference (January 2026)
Conference · 25 slides · Jan 15, 2026
- Q3 2025 Earnings Presentation
Earnings · 27 slides · Nov 12, 2025